Skip to main content
Clinical Trials/NCT06283901
NCT06283901
Recruiting
Not Applicable

Improving Diagnosis and Prediction of Outcome in Patients With Severe Disorders of Consciousness

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)5 sites in 1 country160 target enrollmentJanuary 2, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Traumatic Brain Injury
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Enrollment
160
Locations
5
Primary Endpoint
Glasgow Outcome Scale Extended
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Patients with acute severe brain injury are usually admitted to the Intensive Care Unit. A substantial proportion of these patients will have disorders of consciousness (DOC) after interruption of sedation. It is difficult to reliably predict neurological outcome in these patients. Dependent on the extent of permanently damaged brain areas, DOC in patients with acute severe brain injury may improve or persist, eventually evolving into a minimal conscious state (MCS) or unresponsive wakefulness syndrome (UWS). These conditions are accompanied by long term severe disability. In current practice, the decision to withdraw life-sustaining support is made by interpreting the results of repeated bedside neurological examination and conventional CT-brain imaging. Reliable identification of patients with a possible good outcome, in whom treatment should not be withdrawn, is difficult. In this prospective observational cohort study we aim to identify patients with a good neurological outcome.

Detailed Description

In order to identify patients with a good neurological outcome a combination of diagnostic tests is used. Clinical rating scales * Simplified evaluation of consciousness scale (SECONDs) and the full outline of unresponsiveness (FOUR) score * Once a week Blood biomarkers * Neuron specific enolase, neurofilament light, glial fibrillary acidic protein * Sampling timepoints: 24h, 72h, 7 days and 14 days after brain injury * Serum (STG-5) and plasma (EDTA-6) tubes, aliquoted (4 x 0.5ml) and stored at -80°C EEG with reactivity testing * Standard 21-electrode montage * Stimuli protocol I: a set of 5 stimuli repeated 3 times 1. Auditory: clapping in hands, 2. Auditory: calling patients name loudly, 3. Visual: passive eye opening, 4. Tactile: nasal tickle, 5. Noxious: sternal rub Each stimuli is applied for a duration of 5 seconds and an interval between stimuli of 30 seconds * Stimuli protocol II: Cognitive-motor dissociation test MRI-scan * Sequences considered essential for patient care i.e.T1, T2, FLAIR, DWI/SWI * Preferably, performed between 4-6 weeks after hospital admission

Registry
clinicaltrials.gov
Start Date
January 2, 2023
End Date
September 1, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

prof. dr. Janneke Horn

prof. dr. J. Horn

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Eligibility Criteria

Inclusion Criteria

  • All patients that are admitted to the ICU with the following criteria will be eligible for inclusion:
  • Severe brain injury (GCS ≤ 8) as a result of:
  • Traumatic brain injury
  • Ischemic cerebrovascular accident
  • Intracranial hemorrhage
  • Meningo-encephalitis
  • Subarachnoid hemorrhage
  • Age ≥ 18 years old
  • Written informed consent from legal representatives

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • Absence of informed consent
  • Moribund at ICU admission
  • Progressive neurodegenerative disease
  • Pre-admission life expectancy ≤ 6 months based on comorbidity
  • GCS has been \> 8 prior to inclusion
  • Impossible to include within 24 hours after brain injury

Outcomes

Primary Outcomes

Glasgow Outcome Scale Extended

Time Frame: 6 months

Secondary Outcomes

  • Glasgow Outcome Scale Extended(12 months)

Study Sites (5)

Loading locations...

Similar Trials